We observed that high BACH1 expression along with low RKIP expression (R− B+) associates with significantly worse overall survival when compared to high RKIP and low BACH1 (R+ B−) phenotype in three different cancers: lung adenocarcinoma (LUAD), pancreatic adenocarcinoma (PAAD) and LIHC (liver hepatocellular carcinoma). This evidence concerns the gene BACH1 and cancer.